Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Grifols S.A. (GRFS)

Grifols S.A. (GRFS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Grifols S.A. 152 PARC DE NEGOCIS CAN SANT JOAN SANT CUGAT DEL VALLS BARCELONA U3 08174 ESP

P: 34-93-571-0000

Description:

Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.

Key Statistics

Overview:

Market Capitalization, $K 13,235,338
Shares Outstanding, K 687,550
Annual Sales, $ 5,711 M
Annual Net Income, $ 700,160 K
Last Quarter Sales, $ 1,516 M
Last Quarter Net Income, $ 299,670 K
60-Month Beta 0.61
% of Institutional Shareholders 15.10%
Float, K 687,550
% Float 100.00%

Growth:

1-Year Return -16.64%
3-Year Return -12.10%
5-Year Return 18.64%
5-Year Revenue Growth 28.03%
5-Year Earnings Growth 18.18%
5-Year Dividend Growth -22.73%

Per-Share Information:

Next Earnings Date 11/10/20
Earnings Per Share ttm 1.27
EPS Growth vs. Prev Qtr 2.86%
EPS Growth vs. Prev Year 28.57%
Annual Dividend Rate, $ 0.31
Annual Dividend Yield 1.69%
Most Recent Dividend 0.143 on 10/30/20
Next Ex-Dividends Date 10/30/20
Dividend Payable Date 11/09/20
Dividend Payout Ratio 13.84
Most Recent Split 2-1 on 01/04/16

GRFS Ratios

Ratio
Price/Earnings ttm 14.59
Price/Earnings forward 17.04
Price/Earnings to Growth 1.23
Return-on-Equity % 10.65%
Return-on-Assets % 4.79%
Profit Margin % 12.26
Net Margin % N/A
Debt/Equity 0.97
Price/Sales 2.23
Price/Cash Flow 11.14
Price/Book 1.55
Book Value/Share 12.08
Interest Coverage 3.38

GRFS Dividends

Date Value
10/30/20 $0.1430
12/02/19 $0.1700
06/27/19 $0.1310
06/07/19 $0.0090
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar